$4.620
-0.237 (-5.13%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de WHWK por análisis de gráficos similares
Alphio's WHWK stock price prediction model matches the current Whitehawk Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.72 (+2.12%). The 1-week path is $4.72 (+2.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Whitehawk Therapeutics Inc?
Whitehawk Therapeutics appears to be a good buy right now due to its current price of $4.62, which is significantly lower than the analyst price target of $6.5, suggesting a potential upside of 40%. Additionally, the company has recently secured $87.5 million in PIPE financing, which will extend its cash runway into the second half of 2028, supporting its growth in the oncology market. However, the main risk is its negative earnings per share (EPS) of -0.32 reported for the last quarter, indicating ongoing financial challenges.
WHWK cerró en $4.62 el Friday, tras bajar -5.13%
Whitehawk Therapeutics Inc (WHWK) last closed at $4.62, losing -5.13%. These facts feed the 1-day and 1-week WHWK price prediction above.
Factores de la previsión
Los factores de la previsión de Whitehawk Therapeutics Inc (WHWK) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de WHWK, ordenadas por similitud.
Análisis de estacionalidad de WHWK
Historically the probability of a positive August return for WHWK is 31.75%. March offers the highest probability of a positive month at 61.90%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.